Specialty Drug Prices and Utilization after Loss of U.S. Patent Exclusivity, 2001–2007

Rena Conti and Ernst R. Berndt

A chapter in Measuring and Modeling Health Care Costs, 2016, pp 273-321 from National Bureau of Economic Research, Inc

JEL-codes: D04 I11 I18 L11 L65 (search for similar items in EconPapers)
Date: 2016
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://www.nber.org/chapters/c13100.pdf (application/pdf)

Related works:
Working Paper: Specialty drug prices and utilization after loss of U.S. patent exclusivity, 2001-2007 (2014)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberch:13100

Ordering information: This item can be ordered from
http://www.nber.org/chapters/c13100

Access Statistics for this chapter

More chapters in NBER Chapters from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().